We report herein that vesicular stomatitis virus (VSV) induced a concurrent primary Th1 (T helper 1) and Th2 cytokine response detectable ex vivo. Liposome-encapsulated clodronate-mediated elimination of CD8À marginal dendritic cells (DCs) and splenic macrophages (mA), but not CD8+ interdigitating DCs, prior to infection resulted in a markedly diminished chemokine and Th1 (IL-2, interferon-g) cytokine response, although the Th2 response (IL-4) remained relatively intact. Repopulation with marginal DCs and marginal metallophilic macrophages (MMM) restored Th1 cytokine profiles but did not restore chemokine responsiveness or reduce VSV-induced morbidity/mortality. Chemokine competency returned approximately 4 weeks post-depletion, which correlated temporally with repopulation of the spleen with marginal zone macrophages (MZM) and red pulp macrophages (RPM). Unexpectedly, virus-induced morbidity persisted for over 1 month post-depletion and was associated with virus dissemination and distinctive histological lesions in the liver. Depletion of interferon-producing plasmacytoid dendritic cells did not account for virus-induced morbidity because serum levels of type I interferon were not diminished in Cl2MBP-liposomesome-treated mice. Thus, distinct mA subsets are critical for chemokine production and viral clearance, and, in their absence, VSV disseminates even in the presence of high titers of interferon. D
Introduction
Antiviral immunity depends upon complex and cooperative interactions between different components of the innate and adaptive immune response that cannot be accurately duplicated in vitro. In vivo, this response is orchestrated in part by elaborated chemokines and cytokines that control the migration and activation of both inflammatory cells and antiviral T cells. In addition, contact-dependent signals delivered to CD8+ CTLs by dendritic cells (DCs) and helper T (Th) cells are required for optimal antiviral CTL responses. Thus, depletion of CD4+ cells by genetic manipulation (Karupiah et al., 1996; Shedlock and Shen, 2003) or infusion of anti-CD4 monoclonal antibody (mAb) dramatically suppresses recall CTL responses in vitro and in vivo, demonstrating that CTL priming is CD4-dependent (Ciavarra and Tedeschi, 1994; Shedlock and Shen, 2003; Sun and Bevan, 2003) .
The spleen represents an important and convenient lymphoid organ to study the complex interplay between cells of the innate and adaptive immune response. Bonemarrow-derived macrophage (mA) precursors migrate to specific splenic compartments where they likely undergo further differentiation and function. Several morphologically distinct and compartmentalized mA subpopulations have been described in the murine spleen, such as red pulp macrophages (RPM), marginal metallophilic macrophages (MMM), marginal zone macrophages (MZM) and white pulp macrophages (WPM) (Kraal, 1992) . However, it has been difficult to study collaborative interactions between these cells and the adaptive immune system because defects affecting the innate immune system, particularly macrophages or neutrophils, often compromise the host immunologically and are lethal early in development or shortly after birth. To circumvent these complications, acute depletion has been performed employing liposome-entrapped dicloromethylene biphosphonate clodronate) . This suicide approach demonstrated that depletion of phagocytic cells markedly suppressed immune responses to both complex pathogens and simple protein antigens (Buiting et al., 1996; Cua et al., 1995; Delemarre et al., 1990; Karupiah et al., 1996; Matsushima and Stohlman, 1991) .
Previous reports indicated that Cl2MBP-liposome treatment depleted splenic mA and dendritic cells (DCs) in the marginal sinus (marginal dendritic cells) and markedly suppressed priming for a secondary anti-VSV Th cell and CTL response in vitro (Ciavarra et al., 1997; Leenen et al., 1998) . Subsequent antigen pulse experiments demonstrated that splenic DCs, but not splenic mA, processed and presented VSV peptide/class I and II complexes in situ, even though mA effectively functioned as antigen presenting cells (APC) for VSV T cells in vitro (Ciavarra et al., 2000) . Depletion of marginal DCs and splenic mA did not prevent the accumulation of VSV peptide/class I and II complexes on the remaining CD8+ interdigitating DC population reported to be resistant to liposome-mediated elimination (Leenen et al., 1998) . This suggests that interdigitating DCs can process and present VSV peptides in vivo independent of marginal DCs and other splenic mA subpopulations (Ciavarra et al., 2000) . However, it remains to be determined whether interdigitating DCs alone can induce functional development of antiviral T cells.
The present study examines the contribution of splenic DC and mA subpopulations on antiviral immunity and host resistance. The data indicate that: (i) CD8+ DCs are not sufficient to induce a primary antiviral Th1 cytokine response; (ii) virus-induced chemokine production is dependent on mA with slow repopulation kinetics; (iii) depletion of splenic plasmacytoid DCs does not diminish serum type I interferon (IFN) titers; (iv) in the absence of splenic mA, VSV disseminates ubiquitously even in the presence of high serum titers of IFN. Thus, distinct mA subpopulations play a critical role in host resistance and antiviral immunity most likely by preventing early virus dissemination.
Results

Characterization of the primary anti-VSV Th1 and Th2 cytokine response in vivo
To generate a primary anti-viral type 1 (IL-2) or type 2 (IL-4) cytokine response in vivo, naive mice were given a single injection of either 2 Â 10 7 or 50 Â 10 7 plaque forming units (PFU) VSV. At the indicated times postinfection (p.i.), spleen cells were cultured overnight in ELISPOT plates. Few IL-2-or IL-4-producing cells were detected in mock-infected mice (data not shown). However, in mice infected with 2 Â 10 7 PFU VSV, the frequency of IL-2-producing cells increased with time, peaking on days 4 or 5, and then declined slowly with cytokine-producing cells still detectable 12 -14 days p.i. (Figs. 1A and B and data not shown). Similar kinetics were detected when IFN-g (data not presented) and IL-4 responses (panels C and D) were evaluated. The frequencies of IL-4-and IL-2-secreting cells were approximately the same at the various time points tested, indicating that the IL-4 response was not a minor component of the antiviral cytokine response and occurred in the presence of an ongoing Th1 response in vivo. The decline in the number of cytokine-producing cells was due in part to VSV-induced replication of cells not secreting cytokines. This dilution effect is eliminated when data are expressed as the frequency of cytokine-secreting cells/spleen (panels B and D).
The VSV-induced IL-2 response was dose-dependent because 50 Â 10 7 PFU markedly increased ( P = 0.001) the frequency of IL-2-secreting cells, although a 25-fold increase in infective dose did little to accelerate the kinetics of this response (panel A). This high dose of virus also induced a strong proliferative response in the spleen (data not shown), which accounts for the increase in the total number of IL-2 secreting cells (panel B). A smaller viral dose (1 Â 10 6 PFU) did not elicit a detectable primary anti-VSV IL-2 response (data not shown). IL-2-and IL-4-producing cells were nylon wool non-adherent (NW/NA) and were positively selected with anti-CD4 mAb and magnetic beads (panel E and data not shown). Furthermore, treatment with anti-CD4 but not anti-CD8 mAb plus complement (C) markedly reduced the frequency of IL-2-producing cells (panel E). Additional depletion/enrichment experiments indicated that CD4+ T cells also mediated VSV-induced IL-4 and IFN-g responses (data not presented). The frequency of IL-2-secreting cells was unexpectedly low in fractions enriched for T cells relative to the complement control group. This may have reflected the loss of accessory cells eliminated during T cell isolation that were required for optimal cytokine secretion during overnight incubation in ELISPOT plates. Collectively, these characteristics indicate that VSV induces a primary Th1 (IL-2, IFN-g) and Th2 (IL-4) cytokine response mediated in vivo by CD4+ Th cells.
Elimination of phagocytic cells inhibits the primary VSV-induced T helper 1 cytokine response
Administration of Cl2MBP-liposomes ablates splenic macrophages and marginal DCs but leaves interdigitating DCs intact (Leenen et al., 1998) . Fig. 2 demonstrates that elimination of these cells markedly suppressed the VSV-induced Th1 cytokine response (panels A, B, D, E) both in terms of frequency (ELISPOTS/10 6 cells) and total number (ELISPOTS/spleen) of type 1 cytokinesecreting cells. PBS-entrapped liposomes did not adversely effect phagocytic cells because mice mounted both a Th1 (IL-2, IFN-g) and a Th2 (IL-4) response that was equivalent to that detected in mice treated with PBS ( Fig. 2 and data not shown) . In contrast, the frequency and total number of IL-4-producing cells were similar in PBS and Cl2MBP-liposome-treated mice (panels C and F). These data suggest that interdigitating DCs are not sufficient to induce Th1 cytokine-producing cells following VSV infection despite cell surface expression of VSV peptide/class II complexes in vivo (Ciavarra et al., 2000) .
Interdigitating dendritic cells are not sufficient for a VSV-induced chemokine response
To determine whether CD8+ DCs were sufficient for chemokine production, chemokine mRNA levels were examined in mice treated with Cl2MBP-liposomes. Fig. 3 demonstrates that this suicide technique markedly reduced the number of CDllc+I-A d + DCs but did not deplete CD8+ DCs (panels A and B), confirming prior immunohistochemical studies. In contrast, CD8À marginal DCs were profoundly depleted as were mA that reside in the red pulp and marginal sinus (panels A -C). The numbers of T, B and NK cells in the spleen were not altered by this treatment (data not shown). VSV infection induced elevated levels of CC chemokines RANTES (CCL5), MIP-1a (CCL3), MIP1h (CCL4) and the CXC chemokine MIP-2 (CXCL1) in control mice treated with PBS (panel D). In contrast, mice MZM (g, h) . In a separate but representative experiment, dendritic cell subsets were characterized using antibodies to CD8a, I-A d and B7.2, and the results summarized in panel B. The distribution of class II antigens and costimulatory molecules on RPM (F4/80+) from these animals is presented in panel C. In panels B and C, open and filled hatched bars represent mice infused with PBS or Cl2MBP-liposomes, respectively. (D) PBSand Cl2MBP-liposome-treated mice were rested for 7 days and then infected with VSV. Two days later, spleens were removed, total RNA isolated and assessed for the indicated chemokine mRNA. Each lane was loaded with 5 Ag RNA isolated from mock-infected mice (lane 3), VSV-infected control mice (lane 4) or VSV-infected mice treated 7 days previously with Cl2MBP-liposomes (lane 5). The probe set (mCK5) and control mouse RNA were loaded in lanes 1 and 2, respectively. The gel was deliberately overexposed to highlight chemokine bands. Relative band densities were normalized with L32, a housekeeping gene (E). For this and all subsequent experiments, films were also underexposed to insure that housekeeping gene bands were in the linear range of the film. These gels were then used to correct for any differences in the amount of RNA loaded in each lane. This experiment has been repeated twice and yielded similar results.
treated with Cl2MBP-liposomes failed to mount a detectable chemokine mRNA response. These data indicate that interdigitating DCs are not sufficient to generate a VSVinduced chemokine response.
Splenic repopulation with marginal dendritic cells and marginal metallophilic macrophages fails to render mice competent to produce chemokines If animals were rested an additional week after Cl2MBP-liposome treatment, the spleen became repopulated with normal numbers of DCs composed of approximately equal numbers of B7.2+ and B7.2À DCs (Fig. 4A) . Red pulp macrophage (F4/80+) and MMM (MOMA-1+) numbers were approximately 60% of control values (panel B). However, staining with SER4+, a mAb also specific for MMM, indicated that MMM were present in normal numbers (panel B). The reason for this discrepancy is not clear, but we note that the MOMA-1 antigen distributes both in the cytosol and plasma membrane (Kraal and Janse, 1986) , while the SER-4 antigen is exclusively a cell surface molecule (Crocker et al., 1990) . At this time point, the spleen also contained markedly reduced numbers of MZM (ERTR9+) confirming prior kinetic studies that MZM repopulated the spleen with the slowest kinetics. Despite normal numbers of marginal DCs and MMM, only the VSV-induced MIP-2 response was normal with mRNA levels of the remaining chemokines below mock-infected levels (panels C and D). We also observed in this and the previous study that mice became moribund (ruffled fur, pinched-in sides, weight loss) around 48 h post-VSV infection. We therefore monitored survival of cohorts and observed that the majority of these mice subsequently died between days 4 and 5 p.i.
(panel E).
Reconstitution of chemokine response is dependent on macrophages with slow repopulation kinetics Spleens from mice rested 3 weeks following Cl2MBP-liposome treatment were still markedly deficient in RPM and MZM (Figs. 5A -D). Chemokine mRNA profiles indicated that mRNA levels for RANTES remained suppressed, whereas CXCL1 mRNA levels exceeded the response present in VSV-infected control mice (panels E and F). A similar but less impressive increase was also seen for CCL3, CCL4 and CCL1 (TCA-3). Spleens remained small with reduced cellularity (X = 3.1 Â 10 7 /spleen, n = 4) relative to VSV-infected mice or mice treated similarly with Cl2MBP-liposomes but not infected with VSV (range 8 -11 Â 10 7 / spleen, n = 6). A 3-week rest period was not sufficient for mice to regain resistance to a sublethal dose of VSV because a substantial fraction of cohorts died following virus infection (Fig. 5G) .
With the exception of CXCL1 (MIP-2) which remained elevated, a normal VSV-induced chemokine mRNA profile was eventually achieved 32 days post-Cl2MBP-liposome treatment (Figs. 6A and C) . Despite normal chemokine mRNA profiles, liposome-treated mice became moribund 2 -3 days after VSV infection with an¨50% mortality rate (panel D). Together, these data suggest that slowly repopulating MZM and/or RPM are required to generate a VSV-induced chemokine response in vivo.
Depletion of phagocytic cells promotes systemic virus replication
Because ablation of phagocytic cells was associated with acute illness, virus titers were evaluated in several organs. As expected, virus infection of control (PBS injected) mice did not result in detectable VSV titers in brain, lung, liver or spleen 2 days post-infection (Fig. 7) . In contrast, VSV replicated in lung, liver and spleen of mice treated 7 days previously with Cl2MBP-liposomes. Virus was also detectable in the brain, although titers were low relative to the other organs sampled. Delaying virus infection to allow return of marginal DCs and MMM (day 14) did not reduce viral loads. Indeed, some mice rested for 3 or 4 weeks prior to virus infection still failed to clear VSV 48 h postinfection. At autopsy, gross discoloration of the liver was noted in moribund mice treated with Cl2MBP-liposomes and infected with VSV. Histological evaluation revealed acute necrotizing hepatitis characterized by random, often coalescing foci of necrosis associated with mild neutrophilic infiltrates (panel B). Interestingly, a second distinct lesion was observed where hepatocytes were relatively intact except in areas adjacent to portal veins (panel C). However, portal vein thrombosis with a neutrophilic leukocytoclastic infiltrate was common throughout the section, while bile ducts and hepatic arteries were spared.
Impact of Cl2MBP-liposome treatment on plasmacytoid dendritic cells and interferon production
The failure to control viral dissemination may simply reflect liposome-mediated depletion of interferon-producing pDCs. In control animals, pDCs represented¨10 -20% of the total splenic CD11c+ population with the vast majority expressing class II antigens and variable expression of costimulatory molecules B7.1/2 (Fig. 8A) . Although pDCs could still be detected in the spleen of mice infused with Cl2MBP-liposomes, their numbers were markedly reduced 7 and 14 days post-treatment but returned to normal values 1 week later (panels A and B). Based on these data and a prior report that pDCs are the only detectable interferonproducing cells in the spleen of VSV-infected animals (Barchet et al., 2002) , we speculated that IFN levels should be dramatically reduced in Cl2MBP-liposome treated mice. However, sera from these mice contained IFN titers that were actually higher on days 7 and 14 than those detected in control mice (panel C). These data indicate that elimination of pDCs does not diminish the host's capacity to produce type I IFN in response to infection with VSV.
A normal Th1 cytokine profile is not sufficient to prevent virus dissemination
It is apparent that the ability of the host to produce chemokines and IFN does not insure resistance to VSV. We therefore considered the possibility that persistent virus dissemination reflected the inability to generate protective Th1 cytokines even after several weeks of recovery following Cl2MBP-liposome treatment. To test this hypothesis, the VSV-induced Th1 cytokine response was evaluated at various time points following depletion with Cl2MBP-liposomes. Fig. 9A demonstrates that mice were not capable of producing Th1 cytokines following infection with VSV 1 week after depletion. A profound loss of cellularity was also noted that markedly reduced the total number of splenic cytokine-secreting cells (panel B). However, when mice were allowed to recover an additional week, normal numbers of cytokine-producing cells (panel C) and cellularity (panel D) were detected in the spleen. Thus, failure to control virus replication cannot be attributed solely to a suppressed Th1 cytokine response.
Discussion
We report herein that VSV infection induced a reproducible primary Th1 (IL-2, IFN-g) and Th2 (IL-4) cytokine response in vivo that was detected without further antigen restimulation in vitro. Type I (IL-2, IFN-g) and 2 (IL-4) cytokine responses displayed similar protracted kinetics in that both responses peaked between days 4 and 5 and remained elevated above mock-infected levels for several weeks post-infection. This prolonged response occurred despite rapid clearance of VSV T cell epitopes within 72 h post-infection (Ciavarra et al., 2000) . We were unsuccessful in generating a similar primary response in vitro with VSVinfected DCs and naive T cells (data not presented). Cell fractionation and depletion experiments indicated that CD4+ T cells were the primary source of all cytokines tested. Cytokine-producing CD8+ cells were not detected even after challenge of VSV-immune mice (data not presented). When mice were depleted of phagocytic cells by liposomemediated delivery of Cl2MBP prior to VSV infection, prototypical Th1 cytokines such as IL-2 and IFN-g were profoundly inhibited, whereas IL-4 production was not diminished significantly. This suggests that interdigitating DCs, the only splenic APC population remaining after liposome treatment (Leenen et al., 1998) , are sufficient to induce IL-4 cytokine production. In contrast, production of Th1 cytokines during infection with VSV appears to be dependent on one or several of the depleted phagocytic populations. The most likely candidate for this function is the marginal DCs because they display VSV-derived peptides in vivo and repopulate the spleen 2 weeks post-depletion, a time when Th1 cytokine production returns to normal. A current paradigm suggests that Th cell polarization is mediated by DCs. Implicit in this model is the notion that Th1 versus Th2 differentiation may be fixed immutably for each DC subset (De Smedt et al., 2001; Maldonado-Lopez et al., 1999) . However, accumulating evidence suggests that bacterial compounds markedly influence the polarizing potential of DCs (de Jong et al., 2002; Huang et al., 2001; Whelan et al., 2000) . Viral pathogens, such as herpes simplex virus and influenza virus, appear to regulate DC differentiation in a similar fashion (Kadowaki and Liu, 2002; Lopez et al., 2001) . If microbial products do regulate DC effector cell development and subsequent Th cell polarization as these studies suggest, it is difficult to explain how a single pathogen such as VSV can induce polarizing DCs. However, interdigitating and marginal DCs are located in distinct splenic microenvironments, and they are likely exposed to different VSV-induced chemokine/cytokine signals which may influence DC differentiation pathways during VSV infection. Dendritic-cell-mediated Th cell polarization appears to be the case with VSV because depletion of myeloid DCs markedly suppressed Th1 cytokine production, and the loss of this response was associated with virus dissemination and morbidity. This suggests that the generation of a normal Th1 cytokine profile is protective and depends on the presence of myeloid DCs. The temporal correlation of normal Th1 cytokine response and splenic repopulation with myeloid DCs support the view that this response is driven by this DC subset. However, the ability to generate this response did not prevent virus dissemination and associated morbidity/ mortality. Ongoing studies utilizing tetramers indicate that clonal expansion of CD8+ VSV-specific T cells is only marginally inhibited in mice treated with Cl2MBP-liposomes including moribund mice with a heavy viral load. This may reflect the ability of CD8+ interdigitating DCs to induce T cell clonal expansion. However, upregulation of VLA-4 is suppressed on tetramer+ cells, as is the number of granzyme+ cells (unpublished observation). Thus, development of effector T cells may be dependent on further polarization of marginal DCs induced by chemokine signals derived from repopulating macrophages. This view is supported by studies demonstrating that chemokines can regulate subsequent T cell functions in mice infected with viral pathogens (Salazar-Mather et al., 2000) . As noted herein, VSV induces a reproducible CXC and CC chemokine response in vivo, and CC chemokines, such as CCL5, CCL3 and CCL4 may represent a novel mechanism for DC polarization and T cell differentiation (Zou et al., 2000) . Whether CCL5 (RANTES), a chemokine that does not reappear until 4 weeks after Cl2MBP-liposome treatment, plays a role in DC maturation and VSV Th cell polarization will require further studies in this model.
Infusion of liposome-entrapped Cl2MBP eliminates marginal DCs and splenic mA known to be sources of chemokines required for an inflammatory response (Megjugorac et al., 2004; Nakamichi et al., 2004) . However, this technique does not ablate white pulp macrophages and interdigitating DCs, indicating that these two populations are not sufficient for a detectable chemokine response. A similar argument can be made for marginal DCs and MMM because neither of these populations reconstituted the chemokine response following their reappearance in the spleen. Typical macrophage activities such as phagocytosis and production of reactive oxygen species (ROS) appeared normal, suggesting that the failure of recently arrived MMM to produce chemokines is not due to their functional immaturity (data not presented). Based on repopulation kinetics, the most likely source of chemokines is the slowly repopulating MZM and/or RPM. This view is consistent with preliminary studies indicating that repopulating splenic macrophages isolated from mice treated 2 weeks previously with Cl2MBP-liposomes and then infected with VSV produce MIP-2 ex vivo without further re-stimulation in vitro (data not presented). Of these two populations, we favor a critical role for MZM because prior studies indicated that these cells first reappeared in the spleen outside the marginal sinus 2 -3 weeks post-depletion where they were functionally immature. Normal numbers of functionally mature MZM located within the marginal sinus were not achieved until several additional weeks . The dysregulated chemokine response detected 3 weeks post-depletion would be consistent with this view.
Unexpectedly, Cl2MBP-liposome-treated mice remained susceptible to VSV replication even after 32 days of recovery when DCs and most mA subpopulations have returned to the spleen. Normally, VSV does not replicate to detectable levels in intact mice even when given 2 Â 10 9 PFU i.p. (unpublished observation). Prior studies demonstrated that VSV activates an interferon-producing cell (IPC) that resides in the splenic marginal sinus via signaling through Toll-like receptor 7 (TLR7) and the adapter protein MyD88 (Barchet et al., 2002; Diebold et al., 2004; Lund et al., 2004) . Upon virus stimulation, CD11c+B220+Gr-1+ pDCs release massive amounts of IFN-a/h and TNFa that establish an anti-viral state (Barchet et al., 2002; Wong and Goeddel, 1986) . However, the unexpected morbidity/mortality seen with virus-infected, Cl2MBP-liposome-treated mice did not reflect persistent depletion of interferonproducing pDCs. Although splenic pDCs were depleted by Cl2MBP-liposome treatment, there was no apparent relationship between the presence of splenic pDCs and susceptibility to VSV. For example, VSV disseminated ubiquitously 3 and 4 weeks post-Cl2MBP-liposome treatment, times when the spleen had been completely repopulated with pDCs. These data suggest that either a subpopulation of pDCs resistant to liposome-mediated elimination exists within the host or, alternatively, that cell types other than pDCs produce IFN in response to VSV. With respect to the former possibility, Cl2MBP-liposome treatment depleted CD11c+Gr-1+CD45R(B220)+ cells in the bone marrow, blood, thymus and lymph node (data not presented). A similar conclusion was also reached using a new mAb (PDCA-1) specific for pDCs (unpublished observation). Thus, it seems more likely that a nonplasmacytoid dendritic cell produces type I IFN in response to VSV. This view is consistent with the observation that poly IC induces high titers of IFN without pDC activation (Barchet et al., 2002) . In addition, ongoing studies in a conditional ablation transgenic mouse model indicate that systemic depletion of DCs and pDCs fails to inhibit IFN levels in VSV-infected animals (unpublished observation). Although the cell type(s) producing IFN in VSV-infected mice remains to be identified, VSV induced the expansion of a CD11cÀPDCA-1+ population in the bone marrow of both control and Cl2MBP-liposome-treated mice. The contribution of these cells to IFN production is currently being investigated.
As noted previously, high titers of VSV were detected in both the spleen and liver, and both these organs displayed gross and microscopic abnormalities. For example, decreased cellularity was evident in the spleen, and livers were either discolored (blanched) or swollen and green with engorged gall bladders. Histological examination revealed acute massive hepatocellular necrosis associated with neutrophilic leukocytoclastic thrombophlebitis primarily affecting portal veins. These lesions are similar to those reported for patients chronically infected with hepatitis C virus (Kusano et al., 2000) . Chronic infection with this virus is associated with portal and periportal inflammatory infiltrates composed of DCs and T cells associated with piecemeal necrosis. Production of CC chemokines such as DC-CK1 and RANTES was localized to portal tracks, suggesting that the portal tracks are sites where the anti-viral immune response is initiated in the liver. Whether similar events in the VSV model account for the observed portal vein pathology will require further investigation.
This report indicates that a complex and coordinated interplay between compartmentalized DCs, mA and their secreted chemokines is required for induction of a primary antiviral immune response and viral clearance. This view is highlighted by the inability of mice with high titers of circulating type 1 IFN to inhibit viral dissemination when deficient of certain mf subpopulations. The inability of mice depleted of marginal zone macrophages by Cl2MBP-liposomes to control LCMV (Seiler et al., 1997) and ectromelia virus (Karupiah et al., 1996) replication is consistent with studies reported here with VSV. Similarly, Oehen et al. (2002) reported that mice deficient of marginal zone macrophages due to a genetic deficiency also failed to control VSV replication despite an otherwise normal adaptive immune response. Collectively, these studies indicate that distinct mA populations contribute significantly to host resistance during virus infection most likely by elaboration of chemokines necessary to initiate the innate and adaptive immune response and trapping of circulating virus in secondary lymphoid organs. This concentrates viral pathogens in lymphoid organs preventing dissemination to vital organs, a function that appears enhanced by circulating natural antibodies (Ochsenbein et al., 1999) .
Materials and methods
Mice, virus preparation, infection and generation of primary Th cell responses in vivo BALB/c mice (Jackson Laboratories, Bar Harbor, Maine) were housed in sterile microisolator cages with sterile food, water and bedding. The Institutional Animal Care and Use Committee approved all animal studies. Wildtype VSV (Indiana), provided by Dr. Philip Marcus, University of Connecticut, was grown and assayed as previously described (Marvaldi et al., 1977) . Virus was grown in confluent monolayers of Vero cells and virus titers determined by standard plaque assays (Sekellick and Marcus, 1979) . Unless indicated otherwise, mice were infected with VSV by a single i.p. injection of 2 Â 10 7 PFU.
Liposome-mediated elimination of phagocytic cells in vivo
Prior to VSV infection, mice were depleted of splenic DCs/mA and peritoneal mA with Cl2MBP-liposomes as previously described (Ciavarra et al., 1997) . Briefly, mice were given two i.p injections of Cl2MBP-liposomes 72 and 24 h prior to VSV infection. In some experiments, virus infection was delayed for the indicated times following liposome treatment to allow for differential repopulation of marginal DCs and splenic mA subpopulations. Cl2MBP, a kind gift of Roche Diagnostics GmbH, Mannheim, Germany, was encapsulated in liposomes as previously described (Van Rooijen, 1989) . No differences were noted in animals treated with either PBS or liposome-entrapped PBS. The efficacy of splenic DC/mA depletion was verified by immunohistochemistry or flow cytometry using cell-type specific antibodies .
Chemokine mRNA response
To evaluate VSV-induced chemokine mRNA responses in vivo, mice were given a single i.p. injection of either PBS (mock-infected) or VSV, and, at 48 h p.i., total spleen cell RNA was isolated and probed using the RiboQuant MultiProbe RNase Protection Assay System developed by Pharmingen (San Diego, CA). Protected probes were resolved by electrophoresis on denaturing polyacrylamide gels and detected by autoradiography. Films were scanned with a Powerlook II Scanner (UMAX Data Systems, Inc., Hsinchu, Taiwan, Republic of China) and the relative intensities of the bands quantified using a Digital Science 1D program developed by Kodak (New Haven, CT). Similar chemokine mRNA profiles were obtained 12 h p.i. and were omitted for clarity.
ELISPOT assay
Cytokine-producing cells were estimated by ELISPOT assay following established procedures (Taguchi et al., 1990) . All matched capture and detection antibody pairs were obtained either from BD Biosciences (San Diego, CA) or eBiosciences (San Diego, CA). Spleen cells from either mock-or VSV-infected mice were incubated overnight in ELISPOT plates (Millipore Corporation, Bedford, MA) containing anti-cytokine capture antibodies. No exogenous virus was added during this incubation. The following day, ELISPOTS were developed with horseradish-peroxidaseconjugated avidin (Sigma Chemical Co., St. Louis, MO) and visualized by the addition of 3-amino-9-ethylcarbazole.
Multiparameter flow cytometry
Spleens were incubated with collagenase to promote release of DCs and mA from splenic stroma. Following addition of unconjugated or directly conjugated antibodies and a second wash step, unconjugated antibodies were detected using a biotin-conjugated anti-rat IgG followed by fluorescein (FITC)-conjugated streptavidin. Splenic DCs and mA subpopulations were identified using antibodies to DCs (CD11c/N418, Pharmingen), RPM (F4/80), MMM (MOMA-1, SER4) (Kraal and Janse, 1986) and MZM (ERTR9) (Dijkstra et al., 1985) . Antibodies to mA subpopulations were also obtained either from G. Kraal, Department of Molecular Cell Biology, Vrije Universiteit, Amsterdam, The Netherlands (ERTR9 and MOMA-1), Paul Crocker, Sir William Dunn School of Pathology, Oxford, UK (SER-4) (Crocker et al., 1990) or commercial sources (F4/80, Serotec, Raleigh, NC). Flow cytometric analysis of 20 -200,000 events per sample was performed on a FACScan (Becton-Dickinson, Mountain View, CA) using CELL Quest software (Becton-Dickinson). Gates were set with the use of appropriate isotype controls.
